MedPath

sing electronic monitors and a smartphone app to improve treatment adherence of new pulmonary tuberculosis patients in Tibet, China

Not Applicable
Completed
Conditions
Pulmonary tuberculosis
Infections and Infestations
Respiratory tuberculosis, bacteriologically and histologically confirmed
Registration Number
ISRCTN52132803
Lead Sponsor
Shigatse Centre for Disease Control and Prevention
Brief Summary

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31097023 protocol (added 20/05/2019) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38309280/ (added 09/02/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
276
Inclusion Criteria

1. Newly diagnosed pulmonary TB patients that is managed at outpatients
2. Aged 15 years or older

Exclusion Criteria

1. Having communication impairment (mental, visual, auditory or speech)
2. Having any family members living in the same household that have already been enrolled into the trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of poor adherence measured per month across the 6/7 months of standard WHO DOTS program for new pulmonary TB patients. It will be calculated from monthly-level data for each patient indicating the number of doses missed per month, with poor monthly adherence defined as the patient having missed =20% of doses per month (equivalent to missing =6 out of 30 doses in a month).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath